Altered glycosylation in cancer: A promising target for biomarkers and therapeutics

D Thomas, AK Rathinavel, P Radhakrishnan - Biochimica et Biophysica …, 2021 - Elsevier
Glycosylation is a well-regulated cell and microenvironment specific post-translational
modification. Several glycosyltransferases and glycosidases orchestrate the addition of …

Mucins in cancer: function, prognosis and therapy

DW Kufe - Nature Reviews Cancer, 2009 - nature.com
Epithelia are protected from adverse conditions by a mucous barrier. The secreted and
transmembrane mucins that constitute the mucous barrier are largely unrecognized as …

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches

DW Kufe - Oncogene, 2013 - nature.com
Abstract Mucin 1 (MUC1) is a heterodimeric protein formed by two subunits that is aberrantly
overexpressed in human breast cancer and other cancers. Historically, much of the early …

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

V Kulasingam, EP Diamandis - Nature clinical practice Oncology, 2008 - nature.com
The introduction of technologies such as mass spectrometry and protein and DNA arrays,
combined with our understanding of the human genome, has enabled simultaneous …

Simple sugars to complex disease—mucin-type O-glycans in cancer

MR Kudelka, T Ju, J Heimburg-Molinaro… - Advances in cancer …, 2015 - Elsevier
Mucin-type O-glycans are a class of glycans initiated with N-acetylgalactosamine (GalNAc) α-
linked primarily to Ser/Thr residues within glycoproteins and often extended or branched by …

Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets

SS Dhanisha, C Guruvayoorappan, S Drishya… - Critical reviews in …, 2018 - Elsevier
Mucins are the main structural components of mucus that create a selective protective
barrier for epithelial surface and also execute wide range of other physiological functions …

CA 15-3: uses and limitation as a biomarker for breast cancer

MJ Duffy, D Evoy, EW McDermott - Clinica chimica acta, 2010 - Elsevier
CA 15-3 which detects soluble forms of MUC-1 protein is the most widely used serum
marker in patients with breast cancer. Its main use is for monitoring therapy in patients with …

Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens

S Hakomori - Advances in cancer research, 1989 - Elsevier
Publisher Summary Aberrant glycosylation is the most common phenomenon associated
with oncogenic transformation expressed in cell membranes of animal and human cancer …

[HTML][HTML] Terminal differentiation of human breast cancer through PPARγ

E Mueller, P Sarraf, P Tontonoz, RM Evans, KJ Martin… - Molecular cell, 1998 - cell.com
We have previously demonstrated that PPARγ stimulates the terminal differentiation of
adipocyte precursors when activated by synthetic ligands, such as the antidiabetic …

[HTML][HTML] A review and proposed nomenclature for major proteins of the milk-fat globule membrane

IH Mather - Journal of dairy science, 2000 - Elsevier
The characteristics and possible functions of the most abundant proteins associated with the
bovine milk-fat globule membrane are reviewed. Under the auspices of the Milk Protein …